Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mandik-Nayak

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Arthritis and Rheumatism|February 2, 2012
Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN miceElizabeth Pigott, Laura Mandik-Nayak
Immunologic Research|August 18, 2005
Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritisLaura Mandik-Nayak, Paul M Allen
Clinical Medicine Insights. Pathology|November 29, 2016
IDO2: A Pathogenic Mediator of Inflammatory AutoimmunityLauren M F Merlo, Laura Mandik-Nayak
Current Directions in Autoimmunity|November 1, 2002
B cell anergy and systemic lupus erythematosusSu-jean Seo, Laura Mandik-Nayak, Jan Erikson
Methods in Cell Biology|October 17, 2025
Autoimmune arthritis: Transgenic mouse models and methodsLauren M F Merlo, Weidan Peng, Laura Mandik-Nayak
Immunotherapy|July 20, 2010
Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammationAlexander J Muller, Laura Mandik-Nayak, George C Prendergast
Frontiers in Immunology|May 2, 2022
Impact of IDO1 and IDO2 on the B Cell Immune ResponseLauren M F Merlo, Weidan Peng, Laura Mandik-Nayak
The Journal of Experimental Medicine|August 2, 2006
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell helpLaura Mandik-Nayak, Jennifer Racz, Barry P Sleckman, et al.
Current Opinion in Immunology|September 9, 2008
Role of B cells in systemic lupus erythematosus and rheumatoid arthritisLaura Mandik-Nayak, Natalie Ridge, Michele Fields, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|September 14, 2020
B-Cell-Targeted 3DNA Nanotherapy Against Indoleamine 2,3-Dioxygenase 2 (IDO2) Ameliorates Autoimmune Arthritis in a Preclinical ModelLauren Mf Merlo, Jessica Bowers, Tony Stefanoni, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|February 2, 2012
Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN miceElizabeth Pigott, Laura Mandik-Nayak
Immunologic Research|August 18, 2005
Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritisLaura Mandik-Nayak, Paul M Allen
Clinical Medicine Insights. Pathology|November 29, 2016
IDO2: A Pathogenic Mediator of Inflammatory AutoimmunityLauren M F Merlo, Laura Mandik-Nayak
Current Directions in Autoimmunity|November 1, 2002
B cell anergy and systemic lupus erythematosusSu-jean Seo, Laura Mandik-Nayak, Jan Erikson
Methods in Cell Biology|October 17, 2025
Autoimmune arthritis: Transgenic mouse models and methodsLauren M F Merlo, Weidan Peng, Laura Mandik-Nayak
Immunotherapy|July 20, 2010
Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammationAlexander J Muller, Laura Mandik-Nayak, George C Prendergast
Frontiers in Immunology|May 2, 2022
Impact of IDO1 and IDO2 on the B Cell Immune ResponseLauren M F Merlo, Weidan Peng, Laura Mandik-Nayak
The Journal of Experimental Medicine|August 2, 2006
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell helpLaura Mandik-Nayak, Jennifer Racz, Barry P Sleckman, et al.
Current Opinion in Immunology|September 9, 2008
Role of B cells in systemic lupus erythematosus and rheumatoid arthritisLaura Mandik-Nayak, Natalie Ridge, Michele Fields, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|September 14, 2020
B-Cell-Targeted 3DNA Nanotherapy Against Indoleamine 2,3-Dioxygenase 2 (IDO2) Ameliorates Autoimmune Arthritis in a Preclinical ModelLauren Mf Merlo, Jessica Bowers, Tony Stefanoni, et al.
Pageof 4